Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated May 11, 2023 (3 years ago)

Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Sub-potent Drug

Cause type: Other

Recalls whose stated reason does not fall into the categories above. See the recall's own reason text for the specifics. All other recalls.

What was recalled

Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.

Affected NDC 99000-9278-64

Compare with the code on your package — it is the most precise check available.

Drug: Tirzepatide

Recalling firm
Revive Rx LLC dba Revive Rx Pharmacy
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0771-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Tirzepatide recalls

See all

Other recalls by Revive Rx LLC dba Revive Rx Pharmacy

All 2023 recalls
Class I · High risk

Hcg 6

Non-sterility; bacterial contamination identified as Paenibacillus lautus.

Terminated Microbial contamination Revive Rx LLC dba Revive Rx Pharmacy D-0648-2022